CZ:Ref:DOI:10.1023/A:1008947301735: Difference between revisions
Jump to navigation
Jump to search
imported>Daniel Mietchen (started) |
imported>Daniel Mietchen (prevalence) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{cite journal| author=McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM| title=Chordoma: incidence and survival patterns in the United States, 1973-1995 | {{cite journal| author=McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM| title=Chordoma: incidence and survival patterns in the United States, 1973-1995 | journal=Cancer Causes Control | year= 2001 | volume= 12 | issue= 1 | pages= 1-11 | pmid=11227920 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=11227920 | doi = 10.1023/A:1008947301735 }} | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=11227920 | doi = 10.1023/A:1008947301735 }} | ||
:Reports on a long-term study involving 400 patients with microscopically confirmed [[chordoma]], revealing an overall | :Reports on a long-term study involving 400 patients with microscopically confirmed [[chordoma]], revealing an overall [[prevalence]]<!-- they use the term [[incidence rate]], which would, however, require a definition over a time span, and they are not clear about whether that time span would be the 22 years covered in their study, or one year, or something else--> of about 1 per million in the United States and a median survival time of about 6 years after diagnosis. It also shows that cranial, spinal and sacral locations each represent about one third of the total number of cases, and that males are affected about twice as often as females. | ||
Latest revision as of 05:57, 13 May 2010
McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM (2001). "Chordoma: incidence and survival patterns in the United States, 1973-1995". Cancer Causes Control 12 (1): 1-11. DOI:10.1023/A:1008947301735. PMID 11227920. Research Blogging. [e]
- Reports on a long-term study involving 400 patients with microscopically confirmed chordoma, revealing an overall prevalence of about 1 per million in the United States and a median survival time of about 6 years after diagnosis. It also shows that cranial, spinal and sacral locations each represent about one third of the total number of cases, and that males are affected about twice as often as females.